The application instructions for preparing a health economic evaluation to be attached to the application for reimbursement status and wholesale price for a medicinal product have been updated. The update was prepared in a working committee with participants from the Pharmaceuticals Pricing Board, the Social Insurance Institution of Finland, Finnish Medicines Agency and Pharma Industry Finland.
The revised instructions were published on 1 July 2026 in Finnish, Swedish and English on the website of the Pharmaceuticals Pricing Board and will be applied for applications received in the Pharmaceuticals Pricing Board from 1 August 2026 onwards.
Inquiries
Chief Pharmaceutical Officer Jaana Viikinkoski, tel. 0295 163 532
Chief Pharmaceutical Officer Vilma Westersund, tel. 0295 163 363
Chief Pharmaceutical Officer Senni Lassila, tel. 0295 163 458
Chief Pharmaceutical Officer Veera Silmu, tel. 0295 163 610
E-mail firstname.lastname@gov.fi